Yao Zhang

Yao Zhang

Auto-generated profile, based on publicly available information

Yao Zhang

Department of Biological Sciences, Virginia Tech, Blacksburg, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2020 in Science Signaling
Verified
Journal Article
Closed access
MCMichael A. Casasanta
Michael A. Casasanta
CYChristopher C. Yoo
Christopher C. Yoo
BUBarath Udayasuryan
Barath Udayasuryan
BSBlake E. Sanders
Blake E. Sanders
AUAriana Umaña
Ariana Umaña
DSDaniel J. Slade
Daniel J. Slade
The progression of inflammation-associated colon cancer is driven by resident bacteria.

1 February 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
SGShuo Geng
Shuo Geng
YZYao Zhang
Yao Zhang
CLChristina Lee
Christina Lee
LLLiwu Li
Liwu Li
Dynamically reprogrammed neutrophils serve as critical initiators for the pathogenesis and treatment of atherosclerosis.

1 January 2020 in Molecular Therapy
Verified
Journal Article
Open access
YZYao Zhang
Yao Zhang
NDNa Diao
Na Diao
CLChristina K. Lee
Christina K. Lee
HCHong Wei Chu
Hong Wei Chu
LBLan Bai
Lan Bai
LLLiwu Li
Liwu Li
Tumor-associated immune-suppressive neutrophils are prevalent in various cancers, including colorectal cancer. However, mechanisms of immune-suppressive neutrophils are not well understood. We report that a key innate suppressor, IRAK-M (interleukin-1 receptor-associated kinase M), is critically involved in the establishment of immune-suppressive neutrophils. In contrast to the wild-type (WT) neutrophils exhibiting immune-suppressive signatures of CD11bhighPD-L1highCD80low, IRAK-M-deficient neutrophils are rewired with reduced levels of inhibitory molecules PD-L1 and CD11b, as well as enhanced expression of stimulatory molecules CD80 and CD40. The reprogramming of IRAK-M-deficient neutrophils is mediated by reduced activation of STAT1/3 and enhanced activation of STAT5. As a consequence, IRAK-M-deficient neutrophils demonstrate enhanced capability to promote, instead of suppress, the proliferation and activation of effector T cells both in vitro and in vivo. Functionally, we observed that the transfusion of IRAK-M-/- neutrophils can potently render an enhanced anti-tumor immune response in the murine inflammation-induced colorectal cancer model. Collectively, our study defines IRAK-M as an innate suppressor for neutrophil function and reveals IRAK-M as a promising target for rewiring neutrophils in anti-cancer immunotherapy.

18 February 2025 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ZBZachary R. Baker
Zachary R. Baker
YZYao Zhang
Yao Zhang
HZHaiyan Zhang
Haiyan Zhang
HFHollyn C. Franklin
Hollyn C. Franklin
PSPriscila Beatriz da Silva Serpa
Priscila Beatriz da Silva Serpa
BHBryan B. Hsu
Bryan B. Hsu

22 October 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
SGShuo Geng
Shuo Geng
YZYao Zhang
Yao Zhang
ZYZiyue Yi
Ziyue Yi
RLRan Lu
Ran Lu
LLLiwu Li
Liwu Li
Polarization of low-grade inflammatory monocytes facilitates the pathogenesis of atherosclerosis. However, underlying mechanisms as well as approaches for resolving monocyte polarization conducive to the regression of atherosclerosis are not well established. In this report, we demonstrate that TRIF-related adaptor molecule (TRAM) mediated monocyte polarization in vivo and in vitro. TRAM controlled monocyte polarization through activating Src family kinase c-SRC, which not only induces STAT1/STAT5-regulated inflammatory mediators CCR2 and SIRP-α but also suppresses PPARγ-regulated resolving mediator CD200R. Enhanced PPARγ and Pex5 due to TRAM deficiency facilitated peroxisome homeostasis and reduction of cellular reactive oxygen species, further contributing to the establishment of a resolving monocyte phenotype. TRAM-deficient monocytes propagated the resolving phenotype to neighboring monocytes through CD200R-mediated intercellular communication. At the translational level, we show that TRAM-deficient mice were resistant to high-fat diet–induced pathogenesis of atherosclerosis. We further document that intravenous transfusion of TRAM-deficient resolving monocytes into atherosclerotic mice potently reduced the progression of atherosclerosis. Together, our data reveal that targeting TRAM may facilitate the effective generation of resolving monocytes conducive for the treatment of atherosclerosis.

24 January 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
YZYao Zhang
Yao Zhang
CLChristina Lee
Christina Lee
SGShuo Geng
Shuo Geng
LLLiwu Li
Liwu Li
Although the importance of the tumor immune environment for the modulation of tumorigenesis and tumor regression is becoming increasingly clear, most of the research related to tumor-immune therapies has focused on adaptive immune cells, while the role and regulation of innate leukocytes such as neutrophils remains controversial and less defined. Here we observed that the selective deletion of Tollip, a key innate immune-cell modulator, led to enhanced tumor immune surveillance in a chemically induced colorectal cancer model. Tollip-deficient neutrophils significantly elevated T cell activation through enhanced expression of the costimulatory molecule CD80, and reduced expression of the inhibitory molecule PD-L1. Mechanistically, Tollip deficiency increased STAT5 and reduced STAT1, the transcription factors responsible for the expression of CD80 and PD-L1, respectively. Through adoptive transfer, we demonstrate that Tollip-deficient neutrophils, but not Tollip-deficient monocytes, are sufficient to drive enhanced tumor immune surveillance and reduced colorectal cancer burden in vivo. Our data reveal a strategy for the reprogramming of neutrophil functions conducive for the enhancement of the antitumor immune environment.